Percheron Therapeutics Limited (ASX:PER)

Percheron Therapeutics Revenue

Percheron Therapeutics had revenue of 88.41K AUD in the half year ending December 31, 2025, a decrease of -92.63%. This brings the company's revenue in the last twelve months to 1.74M, down -9.49% year-over-year. In the fiscal year ending June 30, 2025, Percheron Therapeutics had annual revenue of 1.80M, down -39.32%.

• Revenue (ttm): 1.74M
• Revenue Growth: -9.49%
• P/S Ratio: 4.38
• Revenue / Employee: 217.21K
• Employees: 8
• Market Cap: 7.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.80M	-1.17M	-39.32%
Jun 30, 2024	2.97M	1.00M	51.07%
Jun 30, 2023	1.96M	186.87K	10.51%
Jun 30, 2022	1.78M	1.20M	207.72%
Jun 30, 2021	577.76K	-90.67K	-13.56%